Novel therapeutic combination demonstrates more than additive effects in cutaneous T-cell lymphoma

Ítems similars

• Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma
  per: Dulmage, Brittany O., et al.
  Publicat: (2019)
• Therapeutic Advances in Cutaneous T-Cell Lymphoma
  per: Akilov, Oleg E., et al.
  Publicat: (2011)
• Lessons learned from gene expression profiling of cutaneous T-cell lymphoma
  per: Dulmage, B.O., et al.
  Publicat: (2013)
• Cutaneous Manifestations of Unspecified Peripheral T-Cell Lymphoma May Be Indicative of Disease Activity and Predict Response to Therapy
  per: Schowalter, Michael K., et al.
  Publicat: (2012)
• Infectious agents in cutaneous T-cell lymphoma
  per: Mirvish, Ezra D., et al.
  Publicat: (2010)